Health
Scientific Committees
Scientific Steering Committee (former MDSC)
Outcome of discussions
Minutes of the
Scientific Steering Committee Meeting of 22-23 April
1999
1. Welcome, apologies,
introductory remarks, declaration of interest in relation
to the current agenda
Prof.Dr.Pascal welcomed the
participants. He apologised (for 22 and 23 April)
Prof.Dr.W.Bridges and (for 22 April) Prof.Dr.K.Jones,
Prof.Dr.R.Kroes and Prof.Dr.V.Silano. The list of
participants is attached as annex 1.
No member declared an interest
in any of the point of the agenda which could conflict with
his independence.
2. Approval of the
agenda
The draft agenda was approved
without changes. It is attached as annex 2.
3. Approval of the minutes of
the meeting of 18-19 March 1999.
The draft minutes of the
meeting of 18-19 March 1999 were approved without
changes.
4. Work plan for the
SSC
4.1. Progress on
multidisciplinary matters: Antimicrobial
resistance
The chairman of the Working
Group, presented the draft report including the draft
recommendations. He explained that the document was a
synthesis of the inputs of the various WG members and that
it still is subject to editorial changes.
The SSC welcomed the draft
report which was considered multidisciplinary and well
balanced.
After exchange of views it was
concluded that the report could in principle be agreed upon
and that the Working Group had completed its task.
The report will be further
discussed and completed by the SSC with additional specific
sections (e.g., on animal welfare aspects; on the
environmental implications of the development of
antimicrobial resistance). The SSC agreed that aiming for
an encyclopaedic document which covers all possible aspects
in detail would be unrealistic and needlessly delay the
adoption of the basic and essential aspects of opinion as
identified in the mandate. The possibilities for a further
follow-up by the appropriate Scientific Committees were
discussed.
The SSC members were invited to
send, by 3 May 1999 at the latest, their comments,
including concrete written suggestions for amendments to
the chairman and to the Working Group secretariat. On the
basis of these contributions, the WG chairman and the two
vice-chairmen will prepare an updated draft report and
draft recommendations, for discussion and possible adoption
at the SSC meeting of 27-28 May 1999.
4.2 Multidisciplinary matters
relating to TSE/BSE
a.
General report of the work of the TSE/BSE ad-hoc
group.
Prof.Dr.M.Gibney, chairman of
the TSE/BSE ad-hoc group, provided a summary report on the
recent activities of the ad-hoc group. Details are given
under the subsequent points of the minutes.
b.
Reports on specific
issues
b.1. "Fallen stock": The risks
of non conventional transmissible agents, conventional
infectious agents or other hazards such as toxic substances
entering the human food or animal feed chains via raw
material from fallen stock and dead animals (including
also: ruminants, pigs, poultry, fish, wild/exotic/zoo
animals, fur animals, cats, laboratory animals and fish) or
via condemned materials.
At the meeting of 18-19 March
1999, the opinion was adopted as a "preliminary opinion",
and made available to the public for comments
via internet. The Working Group's report was also
made public and open for comments.
Today, 21 comments had been
received from individuals, research institutions, Central
Veterinary Offices of Member States, rendering companies
and professional associations. Prof.Dr.M.Vanbelle, chairman
of the Working Group presented a summary of the comments
received and the results of a preliminary analysis. The
Working Group is now looking into these comments in detail.
The TSE/BSE ad hoc Group is expected to prepare an updated
draft scientific opinion, for submission to the SSC at its
meeting of 27-28 May 1999.
In parallel, an exercise has
started to verify the consistency between this opinion on
"fallen stock", the pending opinion on "intra-species
recycling" and the opinions on gelatine, meat-and-bone
meal, tallow, dicalcium phosphate and hydrolysed proteins,
which were adopted in the course of 1998 and which for
certain issues refer to the opinions on fallen stock and
recycling. Moreover, since the adoption of the first SSC
opinion on products in March 1998, science has evolved and
also for this reason the verification of the consistency is
thus necessary.
b.2. Intra-species recycling of
animal waste (progress report).
It is expected that a draft
will be available for discussion by the SSC at its meeting
of 24-25 June 1999.
b.3. Safety of tallow derived
from bones as a by-product in the gelatine
production.
A draft report is presently
being prepared under contract by a special rapporteur, who
will address the issue of the quantitative assessment of
the safety of bones for the production of gelatine and
tallow. His report will serve as the basis for the Working
Group, which is expected to deliver a final draft report
before the end of June.
b.4. Breeding of
scrapie-resistant sheep
A Working Group has been
created with the mandate and composition as discussed at
the SSC meeting of 17-18 March 1999. The first meeting is
scheduled for 11 May 1999 and it is expected that the
TSE/BSE ad hoc Group will submit a draft opinion for
discussion at the SSC meeting of 24-25 June 1999.
b.5. Human exposure
risk.
The report of the Working Group
"Human Exposure Risk" was distributed for discussion at the
next meeting.
b.6. Assessment of the
geographical BSE risk; modified manual for the assessment
of geographical BSE risk (adoption); decision on
re-assessments
The SSC continued its
discussion that started at its March-meeting on the
experience gained at the first risk assessment exercise,
including the issue of risk classification. Recognising
that the four risk classes used in the first risk
assessment posed certain problems, in particular with
regard to borderline cases, alternative approaches were
discussed. For the time being a continuous scale was
suggested, allowing differentiating between risk levels,
even if it is clear that BSE is present. However, a final
decision on the risk classification has to be made by the
SSC before adopting the final opinion on the geographical
BSE-risk is possible.
Following this discussion and its
discussion at the previous meeting on the experience gained
from the first risk assessment exercise, the SSC adopted a
revised "
opinion on a method for the assessment
of the geographical BSE-risk"
(
- 400 KB)
.
This opinion does not differ
from the previous one in substance but it provides a
clearer presentation of the SSC's approach and clearer
guidelines for the assessment process.
It will serve as a basis for
the next risk assessment exercise early in May.
The SSC felt also a need to
clarify its process and schedule as follows:
-
The SSC started the
evaluation of the epidemiological status of Member
States and third countries in March by assessing the
geographical BSE-risk, focussing on cattle, for a first
group of 12 MS. The reports on these first risk
assessments were communicated to the concerned MS with
an invitation to comment. Substantial comments and
appreciable additional information were
received.
-
Following the first risk
assessment exercise the SSC recognised a need to
clarify certain aspects of its approach. A revised
opinion on a method for assessing the geographical
BSE-risk was prepared and adopted on its meeting of
22/23 April. The manual for the assessment of the
geographical BSE-risk, attached to this opinion, and
its annexes 3 and 4 where overhauled in order to better
communicate the approach developed by the SSC to the
assessing experts. A new annex 3a was added, providing
criteria for assessing the quality of an animal
TSE-surveillance system. A new annex 4a contains the
form to be used by the experts when preparing the
assessment report.
-
At the same meeting the SSC
decided to assess the geographical BSE risk of all MS
and Third Countries by applying the modified manual.
Because the approach is not substantially changed it is
not expected that the outcome of the assessment will
change for the countries already dealt with in March,
except if additional information was in the meantime
provided.
-
In the light of the
valuable comments made by the relevant countries in
response to the first report, the SSC intends again to
ask for comments from all countries for which a risk
assessment will be carried out on the basis of the
revised manual.
-
A group of five Third
Countries and two Member States will be assessed for
the first time in the first week of May. The MS that
had already been assessed in March will be re-assessed
in the second week of May, taking due account of the
comments and additional information received at that
moment. All assessed countries will receive the draft
reports before the end of May with an invitation for
sending comments before end August 1999. A final
verification of the assessments will then be carried
out in September, taking due account of the comments
received.
-
An additional risk
assessment exercise for Third Countries and Member
States that could not have been treated in May will be
organised early in June in order to allow for
sufficient time for commenting before September.
-
In October the SSC will
deliver an opinion on the geographical BSE-risk of all
countries assessed, taking due account of the overall
consistency of the assessments.
-
In the meantime the SSC
will continue to discuss a method for establishing the
epidemiological BSE-status of a country or region. The
outcome of the OIE-plenary in May 1999, and in
particular the discussion on the BSE-chapter of the
code, will be taken into account.
b.7. TSE surveillance
The report of the Working Group
"Animal TSE-Surveillance" was distributed and discussed,
particularly in view of including it into the manual for
the assessment of the geographical BSE-risk. With some
modifications it was agreed to and added to the manual as
annex 3a.
b.8 BSE-status
categories
A brief general discussion was
held and Prof.M.Gibney proposed to draft a discussion paper
and to distribute it to the Members. The issue has to be
taken up at the next meeting.
b.9 Monitoring of the evolution
of the BSE epidemic in the UK
A Working Group has been
created with the mandate and composition as discussed at
the SSC meeting of 17-18 March 1999. The first meeting is
scheduled for 28 April 1999 and it is expected that the
TSE/BSE ad hoc Group will submit a draft partial opinion
for discussion at the SSC meeting of 27-28 May 1999. This
first opinion is likely to cover only the evaluation of the
present evolution of the BSE epidemic as compared to the
(scientifically based) predictions made in 1996 and 1997.
The other aspects of the mandate (e.g., the necessity to
continue the Over Thirty Months Scheme), will be covered at
a later stage.
b.10 Molecular weight of
hydrolysed proteins derived from bovine hides, as a
criterion for safety with respect to BSE (report, for
opinion).
On request from the SSC, the
TSE/BSE ad hoc group therefore addressed the question
whether the condition of 10.000 Daltons, increased the
safety of the product.
On the basis of the reasoning
given in annex 3, the TSE/BSE
ad hoc Group concluded at its meeting of 15 April
1999, that declaring hydrolysed proteins safe if the
resulting peptides are less than 10.000 Daltons, could lead
to a false sense of security. The ad hoc Group further
concluded that the sourcing and (severe) processing
conditions recommended in its opinion of 22-23 October
1998, together with the fact that bovine hides as such are
not a specified risk material, are sufficient conditions
for the final product to be safe. It further reiterated
that any approval of other production processes should be
done on a case by case basis and on the basis of the
results of a report with research results with respect to
the inactivation of TSE/BSE infectivity by the
process.
The Scientific Steering
Committee fully endorsed the above conclusions. It further
decided that the Opinion of 22-23 October 1998 would need
to be updated in view of these conclusions.
b.11 SEAC Subgroup report on
Research and Surveillance for TSEs in sheep.
On 14 April 1999, the Report
Research and Surveillance for TSEs in Sheep,
prepared by a Subgroup of the UK Spongiform Encephalopathy
Advisory Committee (SEAC) became available. It largely, but
not exclusively, addresses issues similar to the ones
addressed in the SSC Opinion of 24-25 September 1998 on
The risk of infection of sheep and goats with BSE
agent. The SEAC Report also puts a number of different
accents and proposes urgent action in a number of
fields.
The Commission therefore
submitted the following questions to the SSC: "
The Scientific Steering
Committee is invited to first provide the Commission with
an opinion on whether or not the SEAC report is, in
general, in line with the SSC opinion of 24-25 September
1998 on The Risk of infection of sheep and goats with the
BSE agent. In addition the SSC is invited to provide an
opinion on whether it is justified to take action as
quickly as possible at Community level, and to what
extent the SEAC recommendations are applicable to the
entire Community."
Following discussion, the SSC
adopted a statement confirming that, whilst recognising the
different mandates that were at the basis of the SSC
opinion and the SEAC Report, both documents are indeed in
line with each other concerning the risk that BSE might
have been introduced into sheep and goats and concerning
the general recommendations that result from the
recognition of this risk. In addition the SSC formulated a
number of considerations. The full text of the statement is
attached to these minutes as Annex 4.
b.12 BSE tests: Progress
report
Mr. J..Moynagh, DG24, Unit B3,
reported on the progress made in the Commission's programme
for the evaluation of diagnostic tests for TSE in bovines.
The sample preparation work, carried out by the IRMM in
Geel Belgium, was now complete. The sets of samples for
testing would be shipped to the four selected laboratories
on 27 April with testing scheduled to commence on 3rd May.
The testing phase is expected to last for 3-4 weeks. The
initial results may therefore be apparent by the end of May
or early June, with a more detailed analysis available a
few weeks later, probably in time for the June meeting of
the SSC. Prof. Osterhaus, who had been nominated to follow
the project for the SSC would be kept informed of
developments.
5. Organisational
matters.
So far, the Scientific Committee
on Plants has expressed opinions on 13 GMO dossiers and one
dossier is still pending. Some of the applications are
now being addressed by the Scientific Committee on Food, in
the framework of the Novel Food Directive.
Profs. Knudsen and Hardy briefed
the SSC on a recent procedural update in the collaboration
between the Scientific Committees on Food (SC-F) and on
Plants (SC-P) in the field of GMOs. In order to further avoid
as much as possible duplication of efforts, the work done by
the SC-P on the genetic construct of GMOs would be provided
to the SC-F. The rapporteur on this subject from the SC-P
would also join the SC-F meetings. In addition the evaluation
results on "Substantial equivalence" of GMOs (plants), will
be provided to the SC-F, as these evaluations are partly
include certain criteria (e.g., plant physiology)
which are equally relevant for the assessment of food safety
aspects.
It was noted that addressing
certain food safety aspects never can be fully excluded
from the evaluation of GMO dossiers by the SC-P when it
addresses the typical "plant" aspects of a dossier. The
chairmen agreed to maintain contact with a view to
optimising the procedure and will communicate their
conclusions in due course
.
6. Co-ordination:
6.1. Call for expression of
interest: new members for Scientific Committees
Since the eight scientific
committees were established in November 1997, several
members have resigned. Also practical experience has shown
that certain committees are understaffed.
To replace a member who has
resigned or to enlarge a committee, the Commission will
choose from the list of the most suitable applicants,
established in 1997, an applicant with the profile
required. If the list does not contain an applicant with an
appropriate profile it is necessary to launch a new
appointment procedure, including a call for expression of
interest.
To reach the greatest possible
number of scientists, the call for expression of interest
should be published in scientific journals specialised in
the field of competence of the committee concerned. The
members of the SSC were asked to indicate as soon as
possible to the secretariat the names of appropriate
scientific journals. The publication is foreseen for
May.
The text of the call for
expression of interest specifying the committees concerned
and the expertise required has been distributed to the
members.
6.2. Reports of the Chairmen
of the 8 Scientific Committees.
The chairmen of Scientific
Committees reported on the activities of their committees
since the last SSC meeting (18-19 March 1999). A summary of
their reports is given in annex 5.
7. Information by the
Commission services on matters related to consumer
health.
Mr.O.Rohte, Directorate General
III (Industry), reported on DG III's present activities in
the field of its Scientific Co-operation Programme (SCOOP).
This Programme was now about to take up the following
additional tasks:
- Task 3.2.6 Provision of
validated methods to support the SCF recommendations
regarding 3-monochlmoropropanediol (3-MCPD) in hydrolysed
vegetable protein (HVP) and other foods.
- Task 3.2.7 Assessment of
dietary intake of Ochratoxin A by the population of EU
Member States ( Part II)
- Task 7.3 Collection of data
on products intended for use in very low calorie
diets
- Task 7.4 Study of the enzymes
used in foodstuffs and collation of data on their
safety.
- Task 9.1 Preparation of a
working document in support of the uniform interpretation
of legislative standards and the laboratory quality
standards prescribed under Directive 93/99.
8. Any other business:
internal SSC seminar on molecular
biology, neuropathology and testing for prion-related
diseases.
The SSC secretariat announced
that this seminar was now planned for the fourth trimester
of 1999, probably October or December.
The meeting ended on Friday 23
April 1999, at 16h30.
The next meeting will be held
in Brussels, on 27-28 May 1999.
Annex 1
: List of participants of the
Scientific Steering Committee meeting of 22-23 April
1999
Members of the SSC
:
Prof. Georges Bories, Prof.
James W. Bridges (not present), Prof. Fulgencio Garrido
Abellán (not present) *, Prof. Michael J. Gibney, Prof.
Anthony R. Hardy, Prof. Philip T. James, Prof. Keith
H.Jones (not present on 22 April 1999), Prof. Fritz
H.Kemper (not present on 23 April 1999 afternoon), Prof.
Werner Klein, Prof. Ib Knudsen, Prof. Robert Kroes (not
present on 22 April 1999), Prof. Albert Osterhaus (not
present on 23 April 1999), Prof. Gérard Pascal, Prof.
Vittorio Silano (not present on 22 April 1999 morning),
Prof. Marcel Vanbelle, Prof. Martin Wierup,
* Dr. Reinhard Ahl replaced Prof.F. Garrido Abellán
on 22-23 April 1999
Participants from the
Commission
:
DG III
: M. Mieschendahl, O. Rohte;
DG V H. Martin;
DG VI D. André
, T. Chalus, M. Florez Droop, I. Peutz;
DG XI V. Matzeit;
DG XII A. Fabre;
DG XXIV: B. Carsin, T. Daskaleros, W. de Klerck, M.
de Solà, C.Diez, F. Drion, J.Kreysa, G. Morosetti,
G.Morrison, J. Moynagh, J.J. Rateau, A. Sanabria, J. Savio,
K. Sbirrazzuoli, W. Schuller, A. Somogyi, J. Vergnettes, R.
Vanhoorde, P.Vossen. Stagiaires: Amélie Raphaël
Annex 2: VERIFY
MODIFICATIONS !!!!!!
Agenda of the Scientific
Steering Committee Meeting of 22-23 April 1999
1. Welcome, apologies,
introductory remarks, declarations of interest
2. Approval of the
agenda
3. Approval of the minutes of
the meeting of 18-19 March 1999.
4. Work plan for the SSC
4.1. Progress on
multidisciplinary matters:
a. Antimicrobial resistance
(report and possible adoption of an opinion).
4.2. Multidisciplinary matters
relating to TSE/BSE
a. Report by the chairman of
the TSE/BSE ad-hoc group, including:
listing of newly established
working groups and their respective progress reports
b. Reports on specific
issues:
Production systems and
products
.
b.1. "Fallen stock":
presentation of the comments received on the preliminary
opinion; adoption of a final opinion.
b.2. Intra-species recycling of
animal waste (progress report).
b.3. Safety of tallow derived
from bones as a by-product in the gelatine production
(progress report and first discussion).
b.4. Breeding of
scrapie-resistant sheep (progress report)
Human exposure risk
.
b.5. Discussion of the draft
report.
Geographical risk
.
b.6. Assessment of the
geographical BSE risk; modified manual for the assessment
of geographical BSE risk (adoption); decision on
re-assessments
b.7. TSE surveillance (progress
report, possible adoption of an opinion)
b.8 BSE-status categories
(progress report, discussion)
b.9 Monitoring of the evolution
of the BSE epidemic in the UK (progress report)
Other items
:
b.10 Molecular weight of
hydrolysed proteins derived from bovine hides, as a
criterion for safety with respect to BSE (report, for
opinion).
b.11 SEAC Subgroup report on
Research and Surveillance for TSEs in sheep.
b.12 BSE tests: progress
report
5. Organisational
matters.
6. Co-ordination:
- Call for expression of
interest: new members for Scientific Committees
- reports of the Chairmen of
the 8 Scientific Committees.
7. Information by the
Commission services on matters related to consumer
health.
8. Any other business.
- internal SSC seminar on
molecular biology, neuropathology and testing for
prion-related diseases.
_____________________
Annex 3
: Short report to the SSC,
adopted by the TSE/BSE
ad hoc Group at its meeting of 15 April 1999 on
the basis of a Working Group report drafted by
Dr.D.M.Taylor.
Subject
: Hydrolysed proteins: are
they more safe if their molecular weight is less than
10kD?
It has been argued that these
products might be considered to be safe if the hydrolysed
proteins have a MW of <10 kD. The basis for such a
suggestion would be the knowledge that PrP
sc has a MW of 27-30kD.
The TSE/BSE ad hoc Group is of
the opinion that the use of such a criterion could lead to
a false sense of security because it is not known whether
protein sub-components or peptides of low MW derived from
PrP
Sc can trigger the conversion of PrP
C to PrP
Sc. However, one needs to bear in mind that the
27-30 kD PrP
Sc is itself a sub-component. It is the
resistant 'core' that remains after proteolytic digestion
of the full-length PrP
Sc protein that has a MW of 33-35kDa. Therefore,
there is existing formal proof that a somewhat truncated
form of PrP
Sc can convert PrP
C into PrP
Sc. It is known that more severely truncated
forms of PrP
C can be converted to PrP
Sc. For example, a PrP
C peptide consisting of only 21 residues had
properties akin to PrP
Sc.
6 It was neurotoxic, and had a tendency to form
amyloid fibrils analogous to the scrapie-associated fibrils
(SAF) found in brain extracts from TSE-infected
individuals. It must be assumed that this truncated form of
PrP
Sc might convert non-truncated PrP
C to PrP
Sc. Also, a form of PrP
C containing only 106 residues (MW approximately
10 kDa) was converted to PrP
Sc
in vitro.
7 In addition, when this truncated PrP was
expressed in transgenic mice that were deficient for
wild-type PrP, these mice developed scrapie when challenged
with the RML strain of mouse-passaged scrapie agent,
demonstrating the convertibility of this 106 residue PrP
C to PrP
Sc.
8 More importantly, when brain-tissue from the
scrapie-infected PrP106 mice was passaged into mice of the
same genotype, they developed scrapie.
8 These data confirm that PrP
C peptides with a MW of approximately 10 kDa can
not only be converted to PrP
Sc, but that they can also convert PrP
C to PrP
Sc. The above data tend to confirm the opinion
that declaring hydrolysed proteins safe if the resulting
peptides are <10 kDa could lead to a false sense of
security.
The TSE/BSE
ad hoc Group considers that only low levels of BSE
infectivity could be present in the raw materials. The two
typical manufacturing processes described in the SSC
opinion of 22-23 October 1998 are likely to completely
inactivate even considerably higher levels of BSE
infectivity than could ever be present under worst-case
conditions. This is because of the combinations of heat
(especially steam under pressure) and alkali that are used.
A variety of data are available that show the effectiveness
of heat combined with alkali on BSE and scrapie
agents.
1-5
References
1.
Ernst, D.R. and Race, R.E. 1993. Comparative
analysis of scrapie agent inactivation. J. Virol.
Methods,41; 193-202.
2.
Prusiner, S.B., McKinley, M.P., Bolton, D.C., Bowman,
K.A., Groth, D.F., Cochran, S.P., Hennessey, E.M.,
Braunfeld, M.B., Baringer, J.R. and Chatigny, M.A.
1984. Prions: methods for assay, purification, and
characterisation. In: K. Maramorosch and H. Koprowski
(Editors), Methods in Virology, 8. Academic Press, New
York, pp 293-345.
3.
Taguchi, F., Tamai, Y., Uchida, K., Kitajima, R.,
Kojima, H., Kawaguchi, T., Ohtani, Y. and Miura, S.
1991. Proposal for a procedure for complete
inactivation of the Creutzfeldt-Jakob disease agent. Arch
Virol, 119; 297-301.
4.
Taylor, D.M, Fernie, K. and McConnell, I., 1997.
Inactivation of the 22A strain of scrapie agent by
autoclaving in sodium hydroxide. Vet Microbiol 58.
87-91.
5.
Taylor, D.M., Fernie, K. & Steele, P.J., 1999.
Boiling in sodium hydroxide inactivates mouse-passaged BSE
agent. Abstracts of a Meeting of the Association of
Veterinary Teachers and Research Workers. p 22.
Scarborough; 29 March-1 April 1999.
6.
Forlini, G., Angeretti, N., Chiesa, R., Monzani, E.,
Salmona, M., Bugiani, O. & Tagliavini, F., 1993.
Neurotoxicity of a prion protein fragment.
Nature
362, 543-546.
7.
Muramoto, T., Scott, M., Cohen, F.E. & Prusiner,
S.B., 1996 Recombinant scrapie-like protein of 106
amino acids is soluble. Proc Nat Acad Sci 93,
15457-16462.
8.
Supattapone,S., Bosque, P., Muramoto, T., Wille, H.,
Aagaard, C., Peretz, D., Nguyen,H.O., Heinrich, C.,
Torchia, C., Safar, J., Cohen, F.E., DeArmond, S.J.
Prusiner, S.B. & Scott, M., 1999. Prion protein of
106 residues creates an artificial transmision barrier for
prion replication in transgenic mice.
Cell
96, 869-878.
Annex 4
:
Statement of the Scientific
Steering Committee on the SEAC Subgroup report on
Research and surveillance for TSEs in sheep,
released in April 1999. Adopted at the SSC meeting of
22-23 April 1999
Following the release in April
1999 of the SEAC Subgroup report on Research and
surveillance for TSEs in sheep, the European Commission
invited the Scientific Steering Committee «
to provide the Commission with an opinion on whether or
not the SEAC report is, in general, in line with the SSC
opinion of 24-25 September 1998 on the Risk of
infection of sheep and goats with the BSE agent
. In addition, the Commission invited the SSC to provide
an opinion on whether it is justified to take action as
quickly as possible at Community level, and to what extent
the SEAC recommendations are applicable to the entire
Community».
Recognising the different
mandates that were at the basis of the SSC opinion and the
SEAC Report, the SSC considers that:
1) Both documents are indeed in
line with each other concerning the risk that BSE might
have been introduced into sheep and goats and concerning
the general recommendations that result from the
recognition of this risk.
2) Whilst the SEAC report
emphasises the situation in the UK, a focus should also be
developed on other European countries with a population of
sheep and/or goats, for example with respect to tracing the
history of feeding practices with ruminant MBM.
3) Discrimination between BSE
and scrapie in sheep and goats is a key-question.
Surveillance and other efforts (e.g., the development of
methods) to identify the presence of BSE in sheep and goats
should therefore be initiated as soon as possible.
4) Along the same lines, an
exercise should be conducted to assess of the possible
geographical risk that BSE has been introduced into sheep.
The method to assess the geographical BSE risk in cattle
which has been developed by the SSC, could be adapted for
that purpose.
5) The TSE/BSE ad hoc Group is
invited to urgently evaluate the SSC and SEAC documents
with respect to actions that need to be taken. It should
report back to the SSC for an opinion at its meeting of
27-28 May 1999.
The SSC further invites the
various Commission services to evaluate their ongoing
research programmes in the light of the research priorities
proposed in both documents, and to take appropriate
action.
Annex 5:
Reports from the secretariats
of Scientific Committees on the major activities and
milestones since the SSC meeting of 18-19 March
1999.
Scientific Committee for
Food
At the SCF Plenary of 24 March
1999 the following opinions were adopted:
-
An opinion on substances
requested for nutritional purposes, which may be used in
the manufacture of foods for particular nutritional
purposes ('PARNUTS'). The SCF was asked for advice on the
establishment of a list of substances with specific
nutritional purposes (vitamins, minerals, trace elements,
amino acids and other substances) intended to be added to
foodstuffs for particular nutritional uses (dietetic
foods), and, where appropriate, the conditions under
which they should be used.
-
Opinion on the safety of
propane, butane and iso-butane as propellant gases for
vegetable oil-based aerosol cooking sprays and
water-based emulsion cooking sprays.
-
Opinion on ethylhydroxyethyl
cellulose as food additive, which is released as addendum
to the "Opinion on re-evaluation of five modified
celluloses" of 13 March 1992.
-
Opinion on Bisphenol A
diglycidyl ether (BADGE) used in food packaging. The
Committee previously evaluated the substance in November
1986 and in June 1996 as a monomer used in the production
of plastic food contact materials. The Committee had been
asked to re-evaluate this substance in view of new
information.
-
Opinion on an additional list
of monomers and additives for food contact materials. The
Committee evaluated a number of monomers and additives
for food contact materials.
A workshop, jointly organised
by DGXXIV and DGIII on approaches for the toxicological
evaluation of chemically defined flavouring substances took
place on 25 March. Participants were the members of the SCF
and a number of experts from university, Industry, US FDA
and Council of Europe. In view of the involvement of the
SCF in establishing an evaluation program for chemically
defined flavouring substances, the purpose of the workshop
was to establish the state of play in this field on the
international level and to give the opportunity to discuss
the different approaches applied under the different
systems.
The workshop will be followed
shortly by meetings of an SCF task force mandated to
elaborate a proposal on this matter.
Scientific Committee on
Plants
The Scientific Committee Plants
has not met in plenary session since the last meeting of
the SSC. However, discussions and the preparation of draft
opinions have continued in Working Groups on mycotoxins in
baby food and the contained use of genetically modified
micro-organisms. The next plenary meeting will be 17-18 May
1999.
Scientific Committee on
Animal Nutrition
The working groups continue
their work on the various questions addressed to SCAN. Some
draft reports are finalised or close to completion and
should be proposed to the next plenary for possible
adoption."
Scientific Committee
Veterinary Measures relating to Public Health
No plenary session took place
since the last SSC. Working Groups on the following topics
were convened: Hormones,
Listeria monocytogenes in ready-to-eat food,
"Simplification exercise".
Scientific Committee on
Animal Health and Animal Welfare
Meetings were held on two
subjects in the period. These involved modifications to
Directive 64/432/EEC which is at an advanced stage and a
report on ventilation standards for vehicles transporting
animals for long distances. It was noted that the question
on the ventilation standards had been expanded to include
periods while the vehicle was stationary. Substantial
progress was made in both issues. It is anticipated that
these reports will be discussed at the meetings of the
respective subcommittees in May.
Scientific Committee for
Medicinal Products and Medical devices
The Scientific Committee for
Medicinal Products and Medical devices adopted two opinions
by written procedure on 24 March 1999:
- The policy regarding the use
of blood and blood products.
- The safety of hides and
skins.
Two others were adopted in the
Plenary Meeting of 14 April 1999:
- Guidelines on the concept of
"clinical superiority" regarding legislation on orphan
medicinal products.
- Toxicological data on
colouring agents for medicinal products: Aluminium.
Scientific Committee
Cosmetic and non-Food Products
Prof. Kemper, the chairman,
reported on the topics dealt with since the last SSC
meeting. Only two Working Parties meetings took place,
during which the following items were discussed :
1. Inventory
: A discussion Paper on
Guidelines for botanical ingredients and derivatives, which
addresses the 12 essential specifications to be taken into
account in order to better identify botanical ingredients,
the nomenclature conventions, examples of labelling and the
toxicological warnings, was presented to the meeting.
Nevertheless, there was discussion on the need for such
detailed information in an inventory.
The necessity for a precise
identification of those plants which are considered as
dangerous and which use in cosmetic products should be
formally forbidden or at least limited has been discussed.
The issue will be the subject of a report.
The nomenclature conventions to
be used in the inventory have been reviewed.
2. Preservatives, Colorants
& Fragrances
: this meeting was mainly devoted
to the fragrance allergy issue and in this context, industry
was invited and afforded the opportunity to contribute to the
scientific review process concerning fragrance ingredient
allergy. In the first place, the perceived size of the
problem as well as its definition were discussed. There was
also agreement on the importance of primary prevention, as
the crucial parameter in addressing fragrance ingredients
allergy, and on secondary prevention : to provide the
necessary information to the consumer.
Furthermore, the WP approved
the fragrance labelling document, which answers one of the
four questions asked by DG III concerning the safety of
fragrance materials.
Draft opinions were prepared
and preliminary discussed on Musk Ketone and Xylene, on
Ketoconazole and on the use of hydrogen peroxide in tooth
paste and certain mouth washes.
Scientific Committee for
Toxicity, Ecotoxicity and the Environment
A.
Since the mentioned SSC meeting
only a working group meeting on
'Tropospheric ozone' took place (16 April 1999). In
the meantime a draft opinion is being worked at. Given
progress made it seems likely that an opinion will be adopted
at the next CSTEE plenary (
7 May 1999, copy of draft agenda is
attached).
B.
A first meeting of the working
group
'Terrestrial environment' took place on the 27
th of April 1999. This is an initiative of the
CSTEE. They will be developing an opinion on
'Available scientific approaches to assess the potential
effects and risks of chemicals on terrestrial
ecosystems'
. This will be a comprehensive document the table
of contents of which was extensively discussed and
assignments given to the different WG members (It will be
necessary for different members to take on the task of being
rapporteurs of individual chapters).
C.
An opinion request was just
received (27 April) from DG XXI. The terms of reference
indicate that the consultation concerns
'Selection of a Community wide mineral oil marking
system - Safety of the preferred product'
. Essentially the opinion of the CSTEE is being
requested on the health risks of a marker product in oils
used for different purposes (fuel for road vehicles as
opposed to heating gas oil).
D.
The
next CSTEE plenary is confirmed for the 7
th of May 1999.
[
©]
- [
HEALTH] - [
SCIENTIFIC COMMITTEES] - [
SCIENTIFIC STEERING COMMITTEE] -
[
OUTCOME OF DISCUSSIONS]
|